Nanoly Bioscience Overview

  • Founded

  • 2012

Founded
  • Status

  • Private

  • Employees

  • 4

Employees
  • Latest Deal Type

  • Accelerator/​Inc

  • Investors

  • 7

Nanoly Bioscience General Information

Description

Developer of a biocompatible polymer technology designed to stabilize temperature-sensitive protein molecules during storage, transport, and use. The company's technology offers a revolutionary type of additive that can extend the temperature-controlled shelf life of unstable molecules and also completely eliminate the need for temperature-controlled storage for some, enabling clients to eliminate refrigeration for vaccines and protein therapeutics.

Contact Information

Website
www.nanoly.info
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 9066 East Colorado Circle
  • Denver, CO 80231
  • United States
+1 (720) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanoly Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 01-Jan-2017 00.000 Completed Generating Revenue
5. Seed Round 10-May-2016 00.000 00.000 000.00 Completed Generating Revenue
4. Grant 14-Feb-2016 0000 Completed Generating Revenue
3. Grant 13-Nov-2014 0000 Completed Generating Revenue
2. Grant 17-Sep-2014 $75K Completed Generating Revenue
1. Grant 01-Jan-2013 $65K Completed Generating Revenue
To view Nanoly Bioscience’s complete valuation and funding history, request access »

Nanoly Bioscience Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 000,000 00.000000 00 00.00 00.00 00 00.00 000
To view Nanoly Bioscience’s complete cap table history, request access »

Nanoly Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biocompatible polymer technology designed to stabilize temperature-sensitive protein molecules during sto
Biotechnology
Denver, CO
4 As of 2022
00.000
000000000000 00.000

000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
000000000 00000 (000
Cambridge, MA
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanoly Bioscience Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Nanoly Bioscience Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Nanoly Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220142919-A1 Dynamic covalently linked hydrogels as stabilization network platforms Pending 06-Mar-2019 00000000
EP-3463485-A1 Photolabile compositions as a stabilization platform Inactive 31-May-2016 00000000000
EP-3463485-A4 Photolabile compositions as a stabilization platform Inactive 31-May-2016 00000000000
US-20190091346-A1 Photolabile compositions as a stabilization platform Inactive 31-May-2016 A61K47/6903

Nanoly Bioscience Executive Team (7)

Name Title Board Seat Contact Info
Balaji Sridhar Ph.D Co-Founder, Chief Executive Officer & Board Member
Mark Tibbitt Ph.D Co-Founder & Chief Technology Officer
Nanxi Liu Co-Founder, Chief Financial Officer & Board Member
You’re viewing 3 of 7 executive team members. Get the full list »

Nanoly Bioscience Board Members (2)

Name Representing Role Since
Balaji Sridhar Ph.D Nanoly Bioscience Co-Founder, Chief Executive Officer & Board Member 000 0000
Nanxi Liu Self Co-Founder, Chief Financial Officer & Board Member 000 0000
To view Nanoly Bioscience’s complete board members history, request access »

Nanoly Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanoly Bioscience Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
iCatalysts Accelerator/Incubator Minority 000 0000 000000 0
OS Fund Venture Capital Minority 000 0000 000000 0
Colorado Office of Economic Development & International Trade SBIC 000 0000 000000 0
Katherine M. Swanson Young Innovator Award Other 000 0000 000000 0
Dell Technologies Corporation 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial